Current stock page

Catalysts

GILD Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareDrug Manufacturers - GeneralScore data as of Sep 4, 2026

GILD

Catalysts
Gilead Sciences, Inc.
Healthcare· Drug Manufacturers - General
AIQ Score
NeutralAIQ Edge 4/10
Low Priority
In Line With Peers
Score data as of Sep 4, 2026
Last price
$151.00
-$0.22 (-0.15%)
Latest market quote
Momentum79
Value37
Quality30
Risk Resilience47
Sentiment71
View financial data

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Oct 29, 2026

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 47/100

Momentum 79/100 and sentiment 71/100 before the next covered event.

Recent coverage
2 articles

Updated Sep 6, 2026 · Sentiment 18.18%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 79/100AIQ Edge 4/10 In Line With Peers
Beat rate
100%
8 of 8 reported periods
Average surprise
+9.7%
Across covered historical reports
Latest result
+6.9%
Aug 4, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Aug 4, 2026-$7.25-$6.75+6.9%$7.4B$7.8B
May 7, 2026$1.91$2.03+6.3%$6.91B$6.96B
Feb 10, 2026$1.81$1.86+2.8%$7.69B$7.93B
Oct 30, 2025$2.13$2.47+16.0%$7.45B$7.77B
Aug 7, 2025$1.96$2.01+2.6%$6.98B$7.08B
Apr 24, 2025$1.78$1.81+1.7%$6.81B$6.67B
Feb 11, 2025$1.74$1.90+9.2%$7.15B$7.57B
Nov 6, 2024$1.53$2.02+32.0%$7.02B$7.55B

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
21
Buy
6
Hold
1
Sell
12-month analyst target
$149.50
-0.99% versus current price
Based on 7 analyst observations. Targets are estimates, not predictions.
Low target
$120.00
-20.53% vs latest price
Average target
$149.50
-0.99% vs latest price
High target
$175.00
+15.90% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateOct 29, 2026

Next known earnings or reporting date.

EPS estimate$2.15

Current analyst expectation for the upcoming report.

Revenue estimate$7.76B

Current analyst expectation for the upcoming report.

Sentiment score71

News pressure around the setup.

Momentum score79

Where event reaction would show up first.

AIQ score47/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
7
Average target
$149.50
Target upside
-0.99%
Target range
$120.00 - $175.00
90-day revisions
2

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
2
Neutral
0
Negative
0
finance.yahoo.com · Sep 5, 2026

Gilead Sciences Just Won Its Third FDA Approval in Less Than 4 Months. Is the Stock Still Underrating This Turnaround Play?

Gilead Sciences is branching out beyond its HIV franchise into oncology and immunology therapies.

finance.yahoo.com · Sep 3, 2026

Is Gilead Sciences Stock Outperforming the S&P 500?

Gilead Sciences has rallied the S&P 500 Index over the past year, and analysts remain highly bullish about the stock’s growth prospects.

Open full news and sentiment

GILD Catalysts FAQ

What are the next catalysts for GILD stock?

GILD's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move GILD stock?

Upcoming events that could move GILD include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could GILD's next earnings report affect the stock?

GILD's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive GILD stock higher?

GILD could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt GILD stock?

GILD could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.